|
|
|
Corporate Profile:
BiPar Sciences
| Summary: |
| BiPar Sciences is focused on the development of PARP inhibitors to treat multiple cancer types. |
| Address: |
400 OysterPoint Blvd.
Suite 200
South San Francisco, CA 94080 |
| Phone
#'s: |
| Main |
(650) 228-1880 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(650) 228-1083 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| BiPar Sciences is a wholly-owned subsidiary of sanofi-aventis. |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
|
|
|
